![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Publisher: Adis International
ISSN: 1173-8324
Source: Inpharma, Vol.1, Iss.1634, 2008-01, pp. : 12-12
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Bisphosphonates: are they useful in breast cancer?
Inpharma, Vol. 1, Iss. 1364, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
On-treatment apolipoprotein levels: predictive benefit?
Inpharma, Vol. 1, Iss. 1271, 2001-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Is There a Growing Role for Endocrine Therapy in the Treatment of Breast Cancer?
By Lønning P.E.
Drugs, Vol. 60, Iss. 1, 2000-07 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Abraxane the best taxane for metastatic breast cancer?
Inpharma, Vol. 1, Iss. 1571, 2007-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Perioperative chemotherapy beneficial in early breast cancer?
Inpharma, Vol. 1, Iss. 1321, 2002-01 ,pp. :